Publication | Closed Access
Ketamine versus ECT for Nonpsychotic Treatment-Resistant Major Depression
227
Citations
22
References
2023
Year
Ketamine was noninferior to ECT as therapy for treatment-resistant major depression without psychosis. (Funded by the Patient-Centered Outcomes Research Institute; ELEKT-D ClinicalTrials.gov number, NCT03113968.).
| Year | Citations | |
|---|---|---|
Page 1
Page 1